论文部分内容阅读
肾活检的诊断和预后价值已被确认。但是,文献资料还未清楚地指出,活检诊断多少次可使肾脏病的治疗发生实质性改变。作者复习了一组作过活检的肾脏病患者的临床材料,以鉴定肾活检对改变治疗的作用。患者100例,男54例,女46例,年龄13—81岁(平均40.1岁)。96例行经皮针刺活检,4例行开放性外科活检。活检适应症分为下列8种:肾病综合征,21例;蛋白尿和肾功能不全,28例;血尿和蛋白尿,15例;蛋白尿,12例;慢性肾功能衰竭,9例;
The diagnostic and prognostic value of renal biopsy has been confirmed. However, the literature has not yet clearly pointed out that the number of biopsy diagnosis can make a substantial change in the treatment of kidney disease. The authors reviewed the clinical materials of a group of patients with kidney disease who had undergone biopsy to identify the role of renal biopsy in changing treatment. 100 patients, 54 males and 46 females, aged 13-81 years (mean 40.1 years). 96 routine needle biopsy, 4 open surgical biopsy. Biopsy indications were divided into the following 8 categories: nephrotic syndrome, 21 cases; proteinuria and renal insufficiency, 28 cases; hematuria and proteinuria, 15 cases; proteinuria, 12 cases; chronic renal failure, 9 cases;